Siegfried Holding AG
SFZN
Kedudukan dalam Saham
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Harga Saham
$88.34
Modal Pasaran
$3.87B
Perubahan (1 hari)
1.68%
Perubahan (1 tahun)
-12.97%
Negara
CH
Perdagangan Siegfried Holding AG (SFZN)
Kategori
Healthcare
Nisbah P/E bagi Siegfried Holding AG (SFZN)
Nisbah P/E pada October 2026 TTM: 18.61
Menurut laporan kewangan dan harga saham terkini Siegfried Holding AG, nisbah P/E semasa (TTM) ialah 18.61. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 26.55.
Sejarah nisbah P/E bagi Siegfried Holding AG dari 2002 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 18.61 | -3.99% |
| 2025 | 19.38 | -27.01% |
| 2024 | 26.55 | -17.81% |
| 2023 | 32.30 | 95.18% |
| 2022 | 16.55 | -57.71% |
| 2021 | 39.13 | -11.81% |
| 2020 | 44.37 | 21.56% |
| 2019 | 36.50 | 50.03% |
| 2018 | 24.33 | -24.83% |
| 2017 | 32.37 | 9.14% |
| 2016 | 29.66 | 49.88% |
| 2015 | 19.79 | 21.74% |
| 2014 | 16.25 | 38.10% |
| 2013 | 11.77 | -40.05% |
| 2012 | 19.63 | -42.83% |
| 2011 | 34.34 | -282.42% |
| 2010 | -18.83 | 157.44% |
| 2009 | -7.31 | 116.99% |
| 2008 | -3.37 | -131.41% |
| 2007 | 10.73 | -31.42% |
| 2006 | 15.64 | 25.79% |
| 2005 | 12.44 | -47.04% |
| 2004 | 23.48 | 195.46% |
| 2003 | 7.95 | 6.16% |
| 2002 | 7.49 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 23.30 | 25.22% |
DE
|
|
| 26.92 | 44.67% |
DE
|
|
| 55.58 | 198.70% |
JP
|
|
| 61.13 | 228.57% |
CH
|
|
| 34.87 | 87.43% |
IN
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.